Skip to content

coriander seed supplementation in diabetes

study of the effect of coriander seed supplementation on the control of glycemic indices ,lipid profile and oxidant / antioxidant status in type 2 diabetic patients: Randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190224042821N2
Enrollment
44
Registered
2019-10-11
Start date
2019-10-23
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabets. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Two daily capsules of coriander seed supplements prepared from Baharan Tabriz Company (500 mg). It will be half an hour before lunch and dinner and for 6 weeks. Int

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Diabetic patients 30 to 60 years old Having diabetes for over 3 years Satisfaction to participate in the project

Exclusion criteria

Exclusion criteria: Smokers, pregnant, lactating - People with complex thyroid disorders, liver, digestive, cardiovascular, renal and ineffective immune system Consumers of nonsteroidal anti-inflammatory drugs and those who are homoeopathic Antioxidant supplement supplements in the last three monthsAntioxidant supplement supplements in the last three months Uncontrolled type 2 diabetes and diabetic patients receiving insulin

Design outcomes

Primary

MeasureTime frame
Blood glucose. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Enzymatic methods.;Lipid profile. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Measurement of total cholesterol, triglyceride and HDL by enzymatic methods and calculation of LDL cholesterol by Friedewald formula.;Oxidant and antioxidant. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Measurement of total antioxidant capacity by colorimetric method and malondialdehyde by TBARS method.;Blood insulin. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELISA.;Insulin resistance. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Measurement of insulin resistance by Homa-IR method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Barzegar

Tabriz University of Medical Sciences

Alibarzegar@hotmail.com+98 41335789532

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026